ACADIA Pharmaceuticals Inc. (ACAD): Price and Financial Metrics
ACADIA Pharmaceuticals Inc. (ACAD)
Today's Latest Price: $46.45 USD
Updated Oct 30 4:00pm
Add ACAD to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ACAD Stock Summary
- For ACAD, its debt to operating expenses ratio is greater than that reported by only 4.71% of US equities we're observing.
- With a price/sales ratio of 18.63, Acadia Pharmaceuticals Inc has a higher such ratio than 92.2% of stocks in our set.
- ACAD's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 10.2% of US stocks.
- If you're looking for stocks that are quantitatively similar to Acadia Pharmaceuticals Inc, a group of peers worth examining would be ESTC, GWPH, PACB, UTHR, and MRAM.
- ACAD's SEC filings can be seen here. And to visit Acadia Pharmaceuticals Inc's official web site, go to www.acadia-pharm.com.
ACAD Stock Price Chart Interactive Chart >
ACAD Price/Volume Stats
| Current price | $46.45 | 52-week high | $58.72 |
| Prev. close | $47.35 | 52-week low | $30.02 |
| Day low | $45.35 | Volume | 1,325,700 |
| Day high | $47.67 | Avg. volume | 1,444,533 |
| 50-day MA | $40.91 | Dividend yield | N/A |
| 200-day MA | $44.08 | Market Cap | 7.32B |
ACADIA Pharmaceuticals Inc. (ACAD) Company Bio
Acadia Healthcare Company is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous system disorders. The company was founded in 1993 and is based in San Diego, California.
Loading social stream, please wait...